|| All ER (D) 293 (Jul)
||Queen's Bench Division (Administrative Court)
||John Howell QC and Stephen Knafler (instructed by Sternberg Reed, Barking) for the claimant.
||Jeremy Hyam (instructed by Capsticks) for the trust.
||18 July 2007
National health service - Drug - Supply of medicine or drug - Drug for treatment of metastatic colorectal cancer - Clinical and cost effectiveness - Difficult decisions panel of primary care trust refusing to make drug available to claimant - Whether panel's decision irrational and unlawful.
National health service Drug. In the instant case, the difficult decisions panel of the primary care trust had taken into account irrelevant matters in its decision to refuse a drug known as Avastin to the claimant, who suffered from metastatic colorectal cancer; it had failed to realise the exceptional circumstances of the claimant's case, having drawn comparisons from a study which showed the effect of the drug on the cohort of other colorectal cancer sufferers, having failed to take into account the fact that all other drugs treatments had been unsuccessful, and the slim but important chance that the claimant's life might be prolonged, if only by a few months, notwithstanding concerns in relation to the allocation of resources. Accordingly, the panel's decision had been unlawful and was quashed.
- Cases related to this particular case that are related to, or discuss this caseView related cases
- The All England Law Reports comprises judgments with headnotes and catchwords indicating the area of law and key issues of the case prepared by legally qualified editorsFind AllER Reports
- Commentary discussing this particular case from LexisLibrary's comprehensive range of titles including Butterworths, Halsbury's and TolleyView related commentary